Cambridge Healthtech Institute's Clinical Biomarkers Operations and Innovation

Cambridge Healthtech Institute's Clinical Biomarkers Operations and Innovation is designed to exchange solutions to overcome operational and scientific challenges with various types of studies, including trials with biomarker-based stratified trials, biomarkers as endpoints, etc. Informed consent, innovative solutions for biospecimen management, and other important topics will be discussed by leading experts from top pharmaceutical companies.